作者检测了肝癌及其它恶性肿瘤患者血清中的抗核抗体(ANA),抗平滑肌细胞抗体(ASMA),抗线粒体抗体(AMA)、类风湿因子(RF)、甲状腺球蛋白抗体(ATG)、微粒体抗体(AMC),并进行了比较研究,尤其观察了由肝硬化转变为肝癌及肝癌手术切除后ANA 的经时变化。检测对象共分四组。Ⅰ组为肝癌患者(70例),Ⅱ组为其它恶性肿瘤(60例)Ⅲ组是慢性肝炎(32例)和肝硬化(31例),Ⅳ组为肝功能正常者(145例)。其中HBs 抗原阳性者Ⅰ、Ⅱ、Ⅲ、Ⅳ组分别为33例、 The authors tested anti-nuclear antibodies (ANA), anti-smooth muscle cell antibodies (ASMA), anti-mitochondrial antibodies (AMA), rheumatoid factor (RF), thyroglobulin antibodies (ATG), and microparticles in the serum of patients with liver cancer and other malignancies. Body antibodies (AMCs), and comparative studies were performed, in particular, the changes over time in ANA after liver cirrhosis and liver cancer resection were observed. The test objects are divided into four groups. Group I was liver cancer patients (70 cases), Group II were other malignant tumors (60 cases). Group III was chronic hepatitis (32 cases) and cirrhosis (31 cases). Group IV was normal liver function (145 cases). Among the HBs antigen positive patients, 33 were in the group I, II, III, and IV, respectively.